IndexCopernicus™ Authors Information
Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
D C Simonson, I A Kourides, M Feinglos, H Shamoon, C T Fischette
Diabetes Care 1997; 20(4):597-606
ICID: 842179
IC™ Value: 10.00
Author's profile available for:
  • H Shamoon - click here